The widespread expression of vimentin across all cell lines further underscores the mesenchymal traits common in aggressive cancer phenotypes and carries poor prognosis, particularly in cases of triple-negative breast cancer [91]. This evidence concerns the gene VIM and triple-negative breast carcinoma.